| 4 | 2026-11-16 | 2026-11-13 | Change in an insider's holdings |
| 13F-HR | 2026-11-12 | 2026-09-30 | Quarterly holdings of an investment manager |
| 4 | 2026-11-03 | 2026-10-30 | Change in an insider's holdings |
| 8-K | 2026-11-03 | 2026-10-30 | Directors or officers leave or join Press release: Pfizer Appoints Cecile Guegan as Chief Financial Officer |
| 10-Q | 2026-11-03 | 2026-09-27 | Quarterly report |
| 8-K | 2026-11-03 | 2026-11-03 | Results of operations Press release: Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance |
| 4 | 2026-10-16 | 2026-10-15 | Change in an insider's holdings |
| SCHEDULE 13G | 2026-10-16 | | Report of a passive holder of more than 5% |
| 4 | 2026-10-14 | 2026-10-13 | Change in an insider's holdings |
| 4 | 2026-10-01 | 2026-09-30 | Change in an insider's holdings |
| 4 | 2026-09-29 | 2026-09-25 | Change in an insider's holdings |
| 4 | 2026-09-29 | 2026-09-25 | Change in an insider's holdings |
| 4 | 2026-09-29 | 2026-09-25 | Change in an insider's holdings |
| 4 | 2026-09-29 | 2026-09-25 | Change in an insider's holdings |
| 4 | 2026-09-29 | 2026-09-25 | Change in an insider's holdings |
| 4 | 2026-09-29 | 2026-09-25 | Change in an insider's holdings |
| 4 | 2026-09-16 | 2026-09-15 | Change in an insider's holdings |
| 4 | 2026-09-01 | 2026-08-31 | Change in an insider's holdings |
| N-PX | 2026-08-31 | 2026-06-30 | N-PX |
| 3 | 2026-08-28 | 2026-08-17 | An insider's first report of holdings |
| 4 | 2026-08-17 | 2026-08-14 | Change in an insider's holdings |
| 13F-HR | 2026-08-13 | 2026-06-30 | Quarterly holdings of an investment manager |
| 4 | 2026-08-12 | 2026-08-12 | Change in an insider's holdings |
| 4 | 2026-08-06 | 2026-08-05 | Change in an insider's holdings |
| 4 | 2026-08-05 | 2026-08-05 | Change in an insider's holdings |
| 4 | 2026-08-05 | 2026-08-05 | Change in an insider's holdings |
| 10-Q | 2026-08-04 | 2026-06-28 | Quarterly report |
| 8-K | 2026-08-04 | 2026-08-04 | Results of operations Press release: Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance |
| 4 | 2026-08-03 | 2026-07-31 | Change in an insider's holdings |
| 4 | 2026-07-16 | 2026-07-15 | Change in an insider's holdings |
| 4 | 2026-07-13 | 2026-07-09 | Change in an insider's holdings |
| 4 | 2026-07-01 | 2026-06-30 | Change in an insider's holdings |
| 4 | 2026-06-30 | 2026-06-26 | Change in an insider's holdings |
| 4 | 2026-06-30 | 2026-06-26 | Change in an insider's holdings |
| 4 | 2026-06-30 | 2026-06-26 | Change in an insider's holdings |
| 4 | 2026-06-30 | 2026-06-26 | Change in an insider's holdings |
| 4 | 2026-06-30 | 2026-06-26 | Change in an insider's holdings |
| 4 | 2026-06-30 | 2026-06-26 | Change in an insider's holdings |
| 8-K | 2026-06-18 | 2026-06-18 | Regulation FD disclosure |
| 8-K | 2026-06-18 | 2026-06-18 | Directors or officers leave or join Press release: Pfizer Announces Chief Financial Officer Transition |
| 4 | 2026-06-16 | 2026-06-15 | Change in an insider's holdings |
| 11-K | 2026-06-16 | 2025-12-31 | Annual report of an employee stock plan |
| 11-K | 2026-06-16 | 2025-12-31 | Annual report of an employee stock plan |
| 4 | 2026-06-10 | 2026-06-09 | Change in an insider's holdings |
| 4 | 2026-06-01 | 2026-05-29 | Change in an insider's holdings |
| 4 | 2026-05-18 | 2026-05-15 | Change in an insider's holdings |
| SCHEDULE 13G/A | 2026-05-12 | | Report of a passive holder of more than 5% (amended) |
| 13F-HR | 2026-05-12 | 2026-03-31 | Quarterly holdings of an investment manager |
| S-8 | 2026-05-05 | | Registration of shares for employee plans |
| 10-Q | 2026-05-05 | 2026-03-29 | Quarterly report |
| 8-K | 2026-05-05 | 2026-05-05 | Results of operations Press release: g Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance |
| 4 | 2026-05-04 | 2026-04-30 | Change in an insider's holdings |
| SCHEDULE 13G | 2026-05-01 | | Report of a passive holder of more than 5% |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 3/A | 2026-04-27 | 2026-04-01 | An insider's first report of holdings (amended) |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 4 | 2026-04-27 | 2026-04-23 | Change in an insider's holdings |
| 8-K | 2026-04-27 | 2026-04-23 | Shareholder vote |
| 4 | 2026-04-17 | 2026-04-15 | Change in an insider's holdings |
| 4 | 2026-04-16 | 2026-04-14 | Change in an insider's holdings |
| 3 | 2026-04-10 | 2026-04-01 | An insider's first report of holdings |
| 4 | 2026-04-01 | 2026-03-31 | Change in an insider's holdings |
| 4 | 2026-03-30 | 2026-03-27 | Change in an insider's holdings |
| 4 | 2026-03-30 | 2026-03-27 | Change in an insider's holdings |
| 4 | 2026-03-30 | 2026-03-27 | Change in an insider's holdings |
| 4 | 2026-03-30 | 2026-03-27 | Change in an insider's holdings |
| 4 | 2026-03-30 | 2026-03-27 | Change in an insider's holdings |
| 4 | 2026-03-30 | 2026-03-27 | Change in an insider's holdings |
| SCHEDULE 13G/A | 2026-03-27 | | Report of a passive holder of more than 5% (amended) |
| 4 | 2026-03-16 | 2026-03-13 | Change in an insider's holdings |
| ARS | 2026-03-12 | 2025-12-31 | Annual report to shareholders |
| DEFA14A | 2026-03-12 | | Additional proxy material |
| DEF 14A | 2026-03-12 | 2026-04-23 | Proxy statement |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-05 | 2026-03-03 | Change in an insider's holdings |
| 4 | 2026-03-03 | 2026-02-27 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 4 | 2026-02-27 | 2026-02-25 | Change in an insider's holdings |
| 10-K | 2026-02-26 | 2025-12-31 | Annual report |
| 4 | 2026-02-24 | 2026-02-23 | Change in an insider's holdings |
| 4 | 2026-02-24 | 2026-02-23 | Change in an insider's holdings |
| 4 | 2026-02-17 | 2026-02-12 | Change in an insider's holdings |
| SCHEDULE 13D/A | 2026-02-13 | | Report of an active holder of more than 5% (amended) |
| SCHEDULE 13G/A | 2026-02-13 | | Report of a passive holder of more than 5% (amended) |
| SCHEDULE 13G/A | 2026-02-13 | | Report of a passive holder of more than 5% (amended) |
| 13F-HR | 2026-02-12 | 2025-12-31 | Quarterly holdings of an investment manager |
| 8-K | 2026-02-03 | 2026-02-03 | Results of operations Press release: g Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance |
| 4 | 2026-02-02 | 2026-01-30 | Change in an insider's holdings |
| 4 | 2026-01-16 | 2026-01-14 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2026-01-05 | 2025-12-31 | Change in an insider's holdings |
| 4 | 2025-12-17 | 2025-12-15 | Change in an insider's holdings |
| 8-K | 2025-12-16 | 2025-12-16 | Regulation FD disclosure Press release: Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance |
| 4 | 2025-12-02 | 2025-11-28 | Change in an insider's holdings |
| 8-K | 2025-11-21 | 2025-11-18 | Other events |
| 424B5 | 2025-11-20 | | Prospectus |
| FWP | 2025-11-19 | | Free writing prospectus |
| 424B3 | 2025-11-18 | | Prospectus |
| 4 | 2025-11-17 | 2025-11-14 | Change in an insider's holdings |
| 13F-HR | 2025-11-13 | 2025-09-30 | Quarterly holdings of an investment manager |
| 8-K | 2025-11-13 | 2025-11-13 | Other events |
| 10-Q | 2025-11-04 | 2025-09-28 | Quarterly report |
| 8-K | 2025-11-04 | 2025-11-04 | Results of operations Press release: g Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance |
| 4 | 2025-11-03 | 2025-10-31 | Change in an insider's holdings |
| 4 | 2025-10-17 | 2025-10-15 | Change in an insider's holdings |
| 4 | 2025-10-16 | 2025-10-14 | Change in an insider's holdings |
| 4 | 2025-10-02 | 2025-09-30 | Change in an insider's holdings |
| 4 | 2025-10-02 | 2025-09-30 | Change in an insider's holdings |
| 4 | 2025-10-02 | 2025-09-30 | Change in an insider's holdings |
| 4 | 2025-10-02 | 2025-09-30 | Change in an insider's holdings |
| 4 | 2025-10-02 | 2025-09-30 | Change in an insider's holdings |
| 4 | 2025-10-02 | 2025-09-30 | Change in an insider's holdings |
| 4 | 2025-09-17 | 2025-09-15 | Change in an insider's holdings |
| 4 | 2025-09-03 | 2025-08-29 | Change in an insider's holdings |
| 4 | 2025-08-19 | 2025-08-15 | Change in an insider's holdings |
| 13F-HR | 2025-08-11 | 2025-06-30 | Quarterly holdings of an investment manager |
| 10-Q | 2025-08-05 | 2025-06-29 | Quarterly report |
| 8-K | 2025-08-05 | 2025-08-05 | Results of operations Press release: g Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance |
| 4 | 2025-08-04 | 2025-07-31 | Change in an insider's holdings |
| 4 | 2025-07-16 | 2025-07-14 | Change in an insider's holdings |
| 4 | 2025-07-02 | 2025-06-30 | Change in an insider's holdings |
| 4 | 2025-07-02 | 2025-06-30 | Change in an insider's holdings |
| 4 | 2025-07-02 | 2025-06-30 | Change in an insider's holdings |
| 4 | 2025-07-02 | 2025-06-30 | Change in an insider's holdings |
| 4 | 2025-07-02 | 2025-06-30 | Change in an insider's holdings |
| 4 | 2025-07-02 | 2025-06-30 | Change in an insider's holdings |
| 4 | 2025-06-17 | 2025-06-13 | Change in an insider's holdings |
| 11-K | 2025-06-16 | 2024-12-31 | Annual report of an employee stock plan |
| 11-K | 2025-06-16 | 2024-12-31 | Annual report of an employee stock plan |
| 4 | 2025-06-03 | 2025-05-30 | Change in an insider's holdings |
| SD | 2025-05-30 | | Specialized disclosure (conflict minerals) |
| 144 | 2025-05-23 | | Notice of a planned sale of restricted shares |
| CERT | 2025-05-20 | | NYSE CERTIFICATION |
| 4 | 2025-05-19 | 2025-05-15 | Change in an insider's holdings |
| 8-A12B | 2025-05-19 | | 8-A12B |
| 8-K | 2025-05-19 | 2025-05-14 | Other events |
| 424B5 | 2025-05-15 | | Prospectus |
| FWP | 2025-05-14 | | Free writing prospectus |
| 424B3 | 2025-05-13 | | Prospectus |
| POSASR | 2025-05-13 | | POSASR |
| 13F-HR | 2025-05-13 | 2025-03-31 | Quarterly holdings of an investment manager |
| 144 | 2025-05-05 | | Notice of a planned sale of restricted shares |
| 10-Q | 2025-05-05 | 2025-03-30 | Quarterly report |
| 4 | 2025-05-02 | 2025-04-30 | Change in an insider's holdings |
| 8-K | 2025-04-29 | 2025-04-29 | Results of operations; Exit or disposal costs Press release: g Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 4 | 2025-04-28 | 2025-04-24 | Change in an insider's holdings |
| 8-K | 2025-04-28 | 2025-04-24 | Shareholder vote |
| 4 | 2025-04-17 | 2025-04-15 | Change in an insider's holdings |
| 4 | 2025-04-14 | 2025-04-10 | Change in an insider's holdings |
| DEFA14A | 2025-04-11 | | Additional proxy material |
| DEFA14A | 2025-04-10 | | Additional proxy material |
| DEFA14A | 2025-04-10 | | Additional proxy material |
| DEFA14A | 2025-04-10 | | Additional proxy material |
| DEFA14A | 2025-04-07 | | Additional proxy material |
| 4 | 2025-04-02 | 2025-03-31 | Change in an insider's holdings |
| 4 | 2025-04-02 | 2025-03-31 | Change in an insider's holdings |
| 4 | 2025-04-02 | 2025-03-31 | Change in an insider's holdings |
| 4 | 2025-04-02 | 2025-03-31 | Change in an insider's holdings |
| 4 | 2025-04-02 | 2025-03-31 | Change in an insider's holdings |
| 4 | 2025-04-02 | 2025-03-31 | Change in an insider's holdings |
| PX14A6G | 2025-03-25 | | Shareholder's letter on a proxy vote |
| SCHEDULE 13D/A | 2025-03-24 | | Report of an active holder of more than 5% (amended) |
| SCHEDULE 13D/A | 2025-03-20 | | Report of an active holder of more than 5% (amended) |
| 4 | 2025-03-18 | 2025-03-14 | Change in an insider's holdings |
| ARS | 2025-03-13 | 2024-12-31 | Annual report to shareholders |
| DEFA14A | 2025-03-13 | | Additional proxy material |
| DEF 14A | 2025-03-13 | 2025-04-24 | Proxy statement |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-06 | 2025-03-04 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4 | 2025-03-03 | 2025-02-27 | Change in an insider's holdings |
| 4/A | 2025-03-03 | 2025-02-22 | Change in an insider's holdings (amended) |
| 4/A | 2025-03-03 | 2025-02-22 | Change in an insider's holdings (amended) |
| 4 | 2025-02-28 | 2025-02-26 | Change in an insider's holdings |
| 4 | 2025-02-28 | 2025-02-26 | Change in an insider's holdings |
| 10-K | 2025-02-27 | 2024-12-31 | Annual report |
| SCHEDULE 13D/A | 2025-02-27 | | Report of an active holder of more than 5% (amended) |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-25 | 2025-02-22 | Change in an insider's holdings |
| 4 | 2025-02-18 | 2025-02-13 | Change in an insider's holdings |
| 4 | 2025-02-14 | 2025-02-13 | Change in an insider's holdings |
| 13F-HR | 2025-02-14 | 2024-12-31 | Quarterly holdings of an investment manager |
| SCHEDULE 13G/A | 2025-02-12 | | Report of a passive holder of more than 5% (amended) |
| SCHEDULE 13G/A | 2025-02-12 | | Report of a passive holder of more than 5% (amended) |
| 4 | 2025-02-04 | 2025-01-31 | Change in an insider's holdings |
| 8-K | 2025-02-04 | 2025-02-04 | Results of operations Press release: Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance |
| SCHEDULE 13D/A | 2025-01-21 | | Report of an active holder of more than 5% (amended) |
| SCHEDULE 13D/A | 2025-01-16 | | Report of an active holder of more than 5% (amended) |
| 4 | 2025-01-15 | 2025-01-13 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2025-01-03 | 2024-12-31 | Change in an insider's holdings |
| 4 | 2024-12-17 | 2024-12-13 | Change in an insider's holdings |
| 4 | 2024-12-17 | 2024-12-13 | Change in an insider's holdings |
| 8-K | 2024-12-17 | 2024-12-17 | Regulation FD disclosure Press release: Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance |
| 4 | 2024-12-02 | 2024-11-29 | Change in an insider's holdings |
| 4 | 2024-12-02 | 2024-11-29 | Change in an insider's holdings |
| 4 | 2024-11-18 | 2024-11-15 | Change in an insider's holdings |
| 4 | 2024-11-18 | 2024-11-15 | Change in an insider's holdings |
| 10-Q | 2024-11-04 | 2024-09-29 | Quarterly report |
| 4 | 2024-11-01 | 2024-10-31 | Change in an insider's holdings |
| 4 | 2024-11-01 | 2024-10-31 | Change in an insider's holdings |
| 4 | 2024-10-31 | 2024-10-30 | Change in an insider's holdings |
| 8-K | 2024-10-29 | 2024-10-29 | Results of operations Press release: Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance |
| 4 | 2024-10-16 | 2024-10-15 | Change in an insider's holdings |
| 4 | 2024-10-16 | 2024-10-15 | Change in an insider's holdings |
| 4 | 2024-10-15 | 2024-10-10 | Change in an insider's holdings |
| 3 | 2024-10-15 | 2024-10-10 | An insider's first report of holdings |
| 8-K | 2024-10-15 | 2024-10-10 | Directors or officers leave or join Press release: Tim Buckley Elected to Pfizer’s Board of Directors |
| 4 | 2024-10-11 | 2024-10-10 | Change in an insider's holdings |
| 4 | 2024-10-11 | 2024-10-10 | Change in an insider's holdings |
| SC 13D/A | 2024-10-03 | | Report of an active holder of more than 5% (amended) |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| 4 | 2024-10-02 | 2024-09-30 | Change in an insider's holdings |
| SC 13D/A | 2024-10-01 | | Report of an active holder of more than 5% (amended) |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| 4 | 2024-09-16 | 2024-09-12 | Change in an insider's holdings |
| SC TO-I/A | 2024-09-13 | | Tender offer by the company (amended) |
| 4 | 2024-09-03 | 2024-08-31 | Change in an insider's holdings |
| 4 | 2024-09-03 | 2024-08-30 | Change in an insider's holdings |
| 4 | 2024-09-03 | 2024-08-30 | Change in an insider's holdings |
| CORRESP | 2024-08-22 | | Letter to the SEC's staff |
| SC TO-I/A | 2024-08-22 | | Tender offer by the company (amended) |
| 4 | 2024-08-16 | 2024-08-15 | Change in an insider's holdings |
| 4 | 2024-08-16 | 2024-08-15 | Change in an insider's holdings |
| 4 | 2024-08-16 | 2024-08-15 | Change in an insider's holdings |
| UPLOAD | 2024-08-15 | | Letter from the SEC's staff |
| 4 | 2024-08-14 | 2024-08-13 | Change in an insider's holdings |
| SC TO-I | 2024-08-12 | | Tender offer by the company |
| 4 | 2024-08-05 | 2024-08-01 | Change in an insider's holdings |
| SC 13D/A | 2024-08-05 | | Report of an active holder of more than 5% (amended) |
| 10-Q | 2024-08-05 | 2024-06-30 | Quarterly report |
| 4 | 2024-08-02 | 2024-07-31 | Change in an insider's holdings |
| 4 | 2024-08-02 | 2024-07-31 | Change in an insider's holdings |
| 4 | 2024-08-02 | 2024-07-31 | Change in an insider's holdings |
| 3 | 2024-08-02 | 2024-08-01 | An insider's first report of holdings |
| SC TO-C | 2024-08-01 | | SC TO-C PRE COMMUNICATION |
| SC TO-C | 2024-07-30 | | SC TO-C PRE COMMUNICATUNS |
| 8-K | 2024-07-30 | 2024-07-30 | Results of operations Press release: Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance |
| SC 13D/A | 2024-07-29 | | Report of an active holder of more than 5% (amended) |
| SC TO-C | 2024-07-26 | | PFIZER SC TO-C |
| 8-K | 2024-07-26 | 2024-07-24 | Directors or officers leave or join; Other events |
| 4 | 2024-07-16 | 2024-07-15 | Change in an insider's holdings |
| 4 | 2024-07-16 | 2024-07-15 | Change in an insider's holdings |
| 4 | 2024-07-16 | 2024-07-15 | Change in an insider's holdings |
| 4 | 2024-07-12 | 2024-07-11 | Change in an insider's holdings |
| 4 | 2024-07-12 | 2024-07-11 | Change in an insider's holdings |
| 4 | 2024-07-12 | 2024-07-11 | Change in an insider's holdings |
| 8-K | 2024-07-10 | 2024-07-09 | Directors or officers leave or join |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 4 | 2024-07-01 | 2024-06-27 | Change in an insider's holdings |
| 3 | 2024-07-01 | 2024-06-27 | An insider's first report of holdings |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 4 | 2024-07-01 | 2024-06-28 | Change in an insider's holdings |
| 8-K | 2024-07-01 | 2024-06-27 | Directors or officers leave or join Press release: Cyrus Taraporevala Elected to Pfizer’s Board of Directors |
| 4 | 2024-06-17 | 2024-06-14 | Change in an insider's holdings |
| 4 | 2024-06-17 | 2024-06-14 | Change in an insider's holdings |
| 11-K | 2024-06-11 | 2023-12-31 | Annual report of an employee stock plan |
| 11-K | 2024-06-11 | 2023-12-31 | Annual report of an employee stock plan |
| 4 | 2024-06-04 | 2024-05-31 | Change in an insider's holdings |
| 4 | 2024-06-04 | 2024-05-31 | Change in an insider's holdings |
| 4 | 2024-06-03 | 2024-05-31 | Change in an insider's holdings |
| SD | 2024-05-31 | | Specialized disclosure (conflict minerals) |
| 8-K | 2024-05-22 | 2024-05-22 | Exit or disposal costs |
| 4 | 2024-05-16 | 2024-05-15 | Change in an insider's holdings |
| 4 | 2024-05-16 | 2024-05-15 | Change in an insider's holdings |
| S-8 | 2024-05-09 | | Registration of shares for employee plans |
| 10-Q | 2024-05-08 | 2024-03-31 | Quarterly report |
| 4 | 2024-05-01 | 2024-04-30 | Change in an insider's holdings |
| 4 | 2024-05-01 | 2024-04-30 | Change in an insider's holdings |
| 8-K | 2024-05-01 | 2024-05-01 | Results of operations Press release: Pfizer Reports First-Quarter 2024 Results |
| 8-K | 2024-04-29 | 2024-04-25 | Shareholder vote |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-26 | 2024-04-25 | Change in an insider's holdings |
| 4 | 2024-04-16 | 2024-04-15 | Change in an insider's holdings |
| 4 | 2024-04-16 | 2024-04-15 | Change in an insider's holdings |
| PX14A6G | 2024-04-16 | | Shareholder's letter on a proxy vote |
| 4 | 2024-04-11 | 2024-04-10 | Change in an insider's holdings |
| 4 | 2024-04-11 | 2024-04-10 | Change in an insider's holdings |
| DEFA14A | 2024-04-11 | | Additional proxy material |
| DEFA14A | 2024-04-11 | | Additional proxy material |
| DEFA14A | 2024-04-11 | | Additional proxy material |
| DEFA14A | 2024-04-09 | | Additional proxy material |
| 4 | 2024-04-01 | 2024-03-28 | Change in an insider's holdings |
| 4 | 2024-04-01 | 2024-03-28 | Change in an insider's holdings |
| 4 | 2024-04-01 | 2024-03-28 | Change in an insider's holdings |
| 4 | 2024-04-01 | 2024-03-28 | Change in an insider's holdings |
| 4 | 2024-04-01 | 2024-03-28 | Change in an insider's holdings |
| 4 | 2024-04-01 | 2024-03-28 | Change in an insider's holdings |
| DEFA14A | 2024-03-28 | | Additional proxy material |
| DEFA14A | 2024-03-28 | | Additional proxy material |
| SC 13D/A | 2024-03-22 | | Report of an active holder of more than 5% (amended) |
| SC 13D/A | 2024-03-19 | | Report of an active holder of more than 5% (amended) |
| 4 | 2024-03-18 | 2024-03-15 | Change in an insider's holdings |
| 4 | 2024-03-18 | 2024-03-15 | Change in an insider's holdings |
| SC 13G/A | 2024-03-15 | | Report of a passive holder of more than 5% (amended) |
| ARS | 2024-03-14 | 2023-12-31 | Annual report to shareholders |
| DEFA14A | 2024-03-14 | | Additional proxy material |
| DEF 14A | 2024-03-14 | 2024-04-25 | Proxy statement |
| 4 | 2024-03-05 | 2024-03-04 | Change in an insider's holdings |
| 4 | 2024-03-01 | 2024-02-28 | Change in an insider's holdings |
| 4 | 2024-02-29 | 2024-02-28 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-28 | 2024-02-27 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| 4 | 2024-02-27 | 2024-02-23 | Change in an insider's holdings |
| S-3ASR | 2024-02-23 | | Automatic shelf registration |
| S-8 | 2024-02-23 | | Registration of shares for employee plans |
| 10-K | 2024-02-22 | 2023-12-31 | Annual report |
| 4 | 2024-02-16 | 2024-02-14 | Change in an insider's holdings |
| 4 | 2024-02-16 | 2024-02-14 | Change in an insider's holdings |
| 4 | 2024-02-16 | 2024-02-14 | Change in an insider's holdings |
| SC 13G/A | 2024-02-14 | | Report of a passive holder of more than 5% (amended) |
| SC 13G/A | 2024-02-14 | | Report of a passive holder of more than 5% (amended) |
| SC 13G/A | 2024-02-14 | | Report of a passive holder of more than 5% (amended) |
| SC 13G/A | 2024-02-14 | | Report of a passive holder of more than 5% (amended) |
| SC 13G/A | 2024-02-14 | | Report of a passive holder of more than 5% (amended) |
| SC 13G/A | 2024-02-13 | | Report of a passive holder of more than 5% (amended) |
| 8-K | 2024-01-30 | 2024-01-30 | Results of operations Press release: Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance |
| SC 13G/A | 2024-01-29 | | Report of a passive holder of more than 5% (amended) |
| SC 13D/A | 2024-01-29 | | Report of an active holder of more than 5% (amended) |
| SC 13G/A | 2024-01-26 | | Report of a passive holder of more than 5% (amended) |
| SC 13D/A | 2024-01-19 | | Report of an active holder of more than 5% (amended) |
| 4 | 2024-01-12 | 2024-01-11 | Change in an insider's holdings |
| 4 | 2024-01-12 | 2024-01-11 | Change in an insider's holdings |
| 4 | 2024-01-12 | 2024-01-11 | Change in an insider's holdings |
| 8-K | 2024-01-10 | 2024-01-10 | Other events Press release: Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation |
| SC 13D/A | 2024-01-10 | | Report of an active holder of more than 5% (amended) |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2024-01-02 | 2023-12-29 | Change in an insider's holdings |
| 4 | 2023-12-29 | 2023-12-29 | Change in an insider's holdings |
| 3 | 2023-12-21 | 2023-12-15 | An insider's first report of holdings |
| 4 | 2023-12-19 | 2023-12-15 | Change in an insider's holdings |
| 4 | 2023-12-19 | 2023-12-15 | Change in an insider's holdings |
| 4 | 2023-12-19 | 2023-12-15 | Change in an insider's holdings |
| 4 | 2023-12-19 | 2023-12-15 | Change in an insider's holdings |
| 4 | 2023-12-19 | 2023-12-15 | Change in an insider's holdings |
| 4 | 2023-12-19 | 2023-12-15 | Change in an insider's holdings |
| 8-K/A | 2023-12-14 | 2023-12-14 | Acquisition or sale of assets completed; Regulation FD disclosure (amended) Press release: Pfizer Completes Acquisition of Seagen |
| 8-K | 2023-12-14 | 2023-12-14 | Results of operations; Regulation FD disclosure Press release: Pfizer Completes Acquisition of Seagen |
| 8-K | 2023-12-13 | 2023-12-13 | Regulation FD disclosure Press release: Pfizer Provides Full-Year 2024 Guidance |
| 8-K | 2023-12-12 | 2023-12-07 | Directors or officers leave or join; Regulation FD disclosure Press release: Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen |
| 4 | 2023-12-04 | 2023-11-30 | Change in an insider's holdings |
| 4 | 2023-12-04 | 2023-11-30 | Change in an insider's holdings |
| 4 | 2023-12-04 | 2023-11-30 | Change in an insider's holdings |
| 4 | 2023-11-16 | 2023-11-15 | Change in an insider's holdings |
| 4 | 2023-11-16 | 2023-11-15 | Change in an insider's holdings |
| 4 | 2023-11-16 | 2023-11-15 | Change in an insider's holdings |
| 10-Q | 2023-11-08 | 2023-10-01 | Quarterly report |
| 8-K | 2023-10-31 | | Press release: Pfizer Reports Third-Quarter 2023 Results |
| 8-K | 2023-10-13 | | Press release: Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance |
| 8-K | 2023-08-01 | | Press release: Pfizer Reports Second-Quarter 2023 Results |
| 8-K | 2023-05-02 | | Press release: Pfizer Reports First-Quarter 2023 Results |
| 8-K | 2023-03-13 | | Press release: Pfizer Invests $43 Billion to Battle Cancer |
| 8-K | 2023-01-31 | | Press release: PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE |
| 8-K | 2022-11-01 | | Press release: PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK |
| 8-K | 2022-07-28 | | Press release: PFIZER REPORTS SECOND-QUARTER 2022 RESULTS |
| 8-K | 2022-05-10 | | Press release: Pfizer to Acquire Biohaven Pharmaceuticals |
| 8-K | 2022-05-03 | | Press release: PFIZER REPORTS FIRST-QUARTER 2022 RESULTS |
| 8-K | 2022-04-12 | | Press release: Pfizer Names David M. Denton Chief Financial Officer |
| 8-K | 2022-02-08 | | Press release: PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 RESULTS |
| 8-K | 2021-11-19 | | Press release: Pfizer Announces Retirement of Chief Financial Officer |
| 8-K | 2021-11-02 | | Press release: PFIZER REPORTS THIRD-QUARTER 2021 RESULTS |
| 8-K | 2021-07-28 | | Press release: PFIZER REPORTS SECOND-QUARTER 2021 RESULTS |
| 8-K | 2021-05-04 | | Press release: PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS |
| 8-K | 2021-02-02 | | Press release: PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS |
| 8-K | 2020-11-16 | | Press release: Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan |
| 8-K | 2020-11-05 | | Press release: Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock |
| 8-K | 2020-10-30 | | Press release: Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn |
| 8-K | 2020-10-27 | | Press release: PFIZER REPORTS THIRD-QUARTER 2020 RESULTS |
| 8-K | 2020-07-28 | | Press release: PFIZER REPORTS SECOND-QUARTER 2020 RESULTS |
| 8-K | 2020-05-22 | | Press release: Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC |
| 8-K | 2020-05-19 | | Press release: Pfizer Prices $4,000,000,000 Debt Offering |
| 8-K | 2020-04-28 | | Press release: PFIZER REPORTS FIRST-QUARTER 2020 RESULTS |
| 8-K | 2020-04-02 | | Press release: SUSAN DESMOND-HELLMANN ELECTED TO PFIZER’S BOARD OF DIRECTORS |
| 8-K | 2020-02-28 | | Press release: JAMES QUINCEY ELECTED TO PFIZER’S BOARD OF DIRECTORS |